246 related articles for article (PubMed ID: 31081165)
1. Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice.
Gluchowski NL; Gabriel KR; Chitraju C; Bronson RT; Mejhert N; Boland S; Wang K; Lai ZW; Farese RV; Walther TC
Hepatology; 2019 Dec; 70(6):1972-1985. PubMed ID: 31081165
[TBL] [Abstract][Full Text] [Related]
2. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
Choi CS; Savage DB; Kulkarni A; Yu XX; Liu ZX; Morino K; Kim S; Distefano A; Samuel VT; Neschen S; Zhang D; Wang A; Zhang XM; Kahn M; Cline GW; Pandey SK; Geisler JG; Bhanot S; Monia BP; Shulman GI
J Biol Chem; 2007 Aug; 282(31):22678-88. PubMed ID: 17526931
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of Pharmacology.
Amin NB; Saxena AR; Somayaji V; Dullea R
Clin Ther; 2023 Jan; 45(1):55-70. PubMed ID: 36690550
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
5. Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids.
Villanueva CJ; Monetti M; Shih M; Zhou P; Watkins SM; Bhanot S; Farese RV
Hepatology; 2009 Aug; 50(2):434-42. PubMed ID: 19472314
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
[TBL] [Abstract][Full Text] [Related]
7. An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis.
Yenilmez B; Wetoska N; Kelly M; Echeverria D; Min K; Lifshitz L; Alterman JF; Hassler MR; Hildebrand S; DiMarzio C; McHugh N; Vangjeli L; Sousa J; Pan M; Han X; Brehm MA; Khvorova A; Czech MP
Mol Ther; 2022 Mar; 30(3):1329-1342. PubMed ID: 34774753
[TBL] [Abstract][Full Text] [Related]
8. Roles of Acyl-CoA:Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes.
Li C; Li L; Lian J; Watts R; Nelson R; Goodwin B; Lehner R
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1080-91. PubMed ID: 25792450
[TBL] [Abstract][Full Text] [Related]
9. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
10. Dietary Macronutrient Composition Determines the Contribution of DGAT1 to Alcoholic Steatosis.
Huang LS; Yuen JJ; Trites MJ; Saha A; Epps CT; Hu Y; Kerolle S; Lee SA; Jiang H; Goldberg IJ; Blaner WS; Clugston RD
Alcohol Clin Exp Res; 2018 Dec; 42(12):2298-2312. PubMed ID: 30192394
[TBL] [Abstract][Full Text] [Related]
11. Role of diacylglycerol O-acyltransferase (DGAT) isoforms in bovine hepatic fatty acid metabolism.
Yang W; Wang S; Loor JJ; Lopes MG; Zhao Y; Ma X; Li M; Zhang B; Xu C
J Dairy Sci; 2022 Apr; 105(4):3588-3600. PubMed ID: 35181144
[TBL] [Abstract][Full Text] [Related]
12. Diacylglycerol acyltransferase-2 (DGAT2) and monoacylglycerol acyltransferase-2 (MGAT2) interact to promote triacylglycerol synthesis.
Jin Y; McFie PJ; Banman SL; Brandt C; Stone SJ
J Biol Chem; 2014 Oct; 289(41):28237-48. PubMed ID: 25164810
[TBL] [Abstract][Full Text] [Related]
13. The triglyceride synthesis enzymes DGAT1 and DGAT2 have distinct and overlapping functions in adipocytes.
Chitraju C; Walther TC; Farese RV
J Lipid Res; 2019 Jun; 60(6):1112-1120. PubMed ID: 30936184
[TBL] [Abstract][Full Text] [Related]
14. CD36 and DGAT2 facilitate the lipid-lowering effect of chitooligosaccharides
Shen X; Liang X; Ji X; You J; Zhuang X; Song Y; Yin H; Zhao M; Zhao L
Food Funct; 2021 Sep; 12(18):8681-8693. PubMed ID: 34351342
[TBL] [Abstract][Full Text] [Related]
15. Hepatic synthesis of triacylglycerols containing medium-chain fatty acids is dominated by diacylglycerol acyltransferase 1 and efficiently inhibited by etomoxir.
Wunderling K; Leopold C; Jamitzky I; Yaghmour M; Zink F; Kratky D; Thiele C
Mol Metab; 2021 Mar; 45():101150. PubMed ID: 33359403
[TBL] [Abstract][Full Text] [Related]
16. DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER.
Rong S; Xia M; Vale G; Wang S; Kim CW; Li S; McDonald JG; Radhakrishnan A; Horton JD
Cell Metab; 2024 Mar; 36(3):617-629.e7. PubMed ID: 38340721
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice.
Liu Y; Millar JS; Cromley DA; Graham M; Crooke R; Billheimer JT; Rader DJ
Biochim Biophys Acta; 2008 Mar; 1781(3):97-104. PubMed ID: 18252207
[TBL] [Abstract][Full Text] [Related]
18. Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model.
Tamura YO; Sugama J; Iwasaki S; Sasaki M; Yasuno H; Aoyama K; Watanabe M; Erion DM; Yashiro H
J Pharmacol Exp Ther; 2021 Nov; 379(3):280-289. PubMed ID: 34535562
[TBL] [Abstract][Full Text] [Related]
19. Intestinal acyl-CoA:diacylglycerol acyltransferase 2 overexpression enhances postprandial triglyceridemic response and exacerbates high fat diet-induced hepatic triacylglycerol storage.
Uchida A; Slipchenko MN; Eustaquio T; Leary JF; Cheng JX; Buhman KK
Biochim Biophys Acta; 2013 Aug; 1831(8):1377-85. PubMed ID: 23643496
[TBL] [Abstract][Full Text] [Related]
20. Histone Demethylase KDM7A Contributes to the Development of Hepatic Steatosis by Targeting Diacylglycerol Acyltransferase 2.
Kim JH; Nagappan A; Jung DY; Suh N; Jung MH
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
